SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000902664-22-005090
Filing Date
2022-12-09
Accepted
2022-12-09 17:00:22
Documents
1
Group Members
DAVID JOHNSON

Document Format Files

Seq Description Document Type Size
1 ADMA BIOLOGICS, INC. p22-2586sc13da.htm SC 13D/A 51112
  Complete submission text file 0000902664-22-005090.txt   52751
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Subject) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82025 | Film No.: 221455462
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 590 MADISON AVENUE NEW YORK NY 10022
Business Address 590 MADISON AVENUE NEW YORK NY 10022 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

IRS No.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A